| Diet and Systemic Inflammation (NCT01424306) | Fred Hutchinson Cancer Center | 2011-10-01 |
| Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients (NCT02533648) | Hospices Civils de Lyon | 2011-09-16 |
| Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects (NCT01441986) | Profil Institut für Stoffwechselforschung GmbH | 2011-09-01 |
| A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria (NCT01440257) | Amgen | 2011-09-01 |
| Liraglutide Treatment to Patients With Severe Renal Insufficiency (NCT01394341) | Bo Feldt-Rasmussen | 2011-09-01 |
| Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (NCT01425359) | Gilead Sciences | 2011-09-01 |
| Egg Protein Hydrolysate and Vascular Function (NCT01559896) | Maastricht University Medical Center | 2011-09-01 |
| Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus (NCT01545024) | Nagaoka Red Cross Hospital | 2011-09-01 |
| Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients (NCT01486680) | North Shore Hospital, New Zealand | 2011-09-01 |
| Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus (NCT01441921) | Institut Investigacio Sanitaria Pere Virgili | 2011-09-01 |
| Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus (NCT01472614) | Dexa Medica Group | 2011-09-01 |
| Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study (NCT01417897) | ikfe-CRO GmbH | 2011-09-01 |
| The Effects of Bethanechol on Glucose Homeostasis (NCT01434901) | Washington University School of Medicine | 2011-08-15 |
| Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) (NCT01234649) | Woman's | 2011-08-11 |
| A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009) (NCT01407276) | Merck Sharp & Dohme LLC | 2011-08-08 |
| Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus (NCT01964963) | Takeda | 2011-08-03 |
| Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects (NCT01585818) | National University Hospital, Singapore | 2011-08-01 |
| Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes (NCT01378117) | Emory University | 2011-08-01 |
| Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes (NCT01413204) | Tanabe Pharma Corporation | 2011-07-01 |
| Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients (NCT01593371) | Tehran University of Medical Sciences | 2011-07-01 |
| Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes (NCT01176578) | Baltimore VA Medical Center | 2011-07-01 |
| Cost Effectiveness of Glargine Insulin Versus NPH Insulin (NCT01832935) | Tehran University of Medical Sciences | 2011-07-01 |
| Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532 (NCT01369602) | Pfizer | 2011-07-01 |
| Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222) (NCT01373450) | Merck Sharp & Dohme LLC | 2011-06-01 |
| Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin (NCT01376557) | Lexicon Pharmaceuticals | 2011-06-01 |
| The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass (NCT01843855) | Adrian Vella | 2011-06-01 |
| Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil (NCT01365091) | AstraZeneca | 2011-06-01 |
| Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers (NCT01386541) | Nycomed | 2011-06-01 |
| Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes (NCT04371497) | University Hospital, Caen | 2011-06-01 |
| ET-blockade and Exercise Induced Blood Flow in T2DM (NCT01779596) | Radboud University Medical Center | 2011-05-01 |
| Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone (NCT01529541) | JW Pharmaceutical | 2011-05-01 |
| Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402) (NCT01278485) | Merck Sharp & Dohme LLC | 2011-05-01 |
| Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus (NCT01677013) | Peking University Aerospace Center Hospital | 2011-05-01 |
| A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients (NCT01529528) | JW Pharmaceutical | 2011-05-01 |
| GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes (NCT01414556) | Mikkel Christensen | 2011-05-01 |
| A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM) (NCT01386099) | Prosidion Ltd. | 2011-05-01 |
| JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients (NCT01269996) | Chinese University of Hong Kong | 2011-05-01 |
| A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) (NCT01334203) | Gilead Sciences | 2011-05-01 |
| Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (NCT01353469) | Sanofi | 2011-05-01 |
| Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus (NCT01387737) | Tanabe Pharma Corporation | 2011-05-01 |
| Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses (NCT03648424) | Brigham and Women's Hospital | 2011-05-01 |
| Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes (NCT01334229) | Laval University | 2011-04-01 |
| Glucolipotoxicity and Type 2 Diabetes (NCT01375270) | Rigshospitalet, Denmark | 2011-04-01 |
| Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes (NCT01356381) | Novartis Pharmaceuticals | 2011-04-01 |
| Drug-drug Interaction Study(CKD-501, Amlodipine) (NCT01341392) | Chong Kun Dang Pharmaceutical | 2011-04-01 |
| Vitamin D and Omega-3 Inhibit Metabolic Syndrome (NCT01326442) | University of Guelph | 2011-04-01 |
| A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes (NCT01674348) | Piramal Enterprises Limited | 2011-04-01 |
| Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes (NCT01357252) | Novartis Pharmaceuticals | 2011-04-01 |
| A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus (NCT01862939) | Daiichi Sankyo | 2011-04-01 |
| Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes (NCT01341067) | Rocky Mountain Diabetes and Osteoporosis Center | 2011-04-01 |
| The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital Study (NCT01323114) | McKenzie Health System | 2011-04-01 |
| Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes (NCT01322711) | University of Roma La Sapienza | 2011-03-01 |
| Metabolic Phenotyping in Humans (NCT01298375) | Maastricht University Medical Center | 2011-03-01 |
| Diet Oil Induced Stimulation of GLP-1 (NCT01453842) | University of Copenhagen | 2011-03-01 |
| Drug-drug Interaction Study (CKD-501, Ketoconazole) (NCT01330563) | Chong Kun Dang Pharmaceutical | 2011-03-01 |
| Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in Diabetes (NCT01410292) | Hospital de Clinicas de Porto Alegre | 2011-03-01 |
| Colesevelam for Children With Type 2 Diabetes (NCT01258075) | Daiichi Sankyo | 2011-02-24 |
| Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes (NCT01301833) | Tanabe Pharma Corporation | 2011-02-01 |
| Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions (NCT01315977) | The Hong Kong Polytechnic University | 2011-02-01 |
| Periodontal Treatment and Metabolic Control in Type 2 Diabetic Patients (NCT01291875) | University of Sao Paulo | 2011-02-01 |
| A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects (NCT01292993) | Lexicon Pharmaceuticals | 2011-02-01 |
| Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist (NCT01381926) | University of Alabama at Birmingham | 2011-02-01 |
| Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus (NCT01319734) | Al-Neelain University | 2011-02-01 |
| Metabolic Activation With Protein-rich Formula Diet (NCT02230501) | West German Center of Diabetes and Health | 2011-02-01 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (NCT01972893) | Zydus Lifesciences Limited | 2011-02-01 |
| Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India (NCT01292018) | AstraZeneca | 2011-02-01 |
| Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130) (NCT01177384) | Merck Sharp & Dohme LLC | 2011-01-25 |
| A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment (NCT01316094) | Astellas Pharma Inc | 2011-01-18 |
| A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients (NCT01316107) | Astellas Pharma Inc | 2011-01-15 |
| Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401) (NCT01285076) | Merck Sharp & Dohme LLC | 2011-01-10 |
| Metformin Treatment, Renal Function and Lactic Acidosis (NCT01358994) | Skane University Hospital | 2011-01-01 |
| Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus (NCT01293669) | Targacept Inc. | 2011-01-01 |
| Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients (NCT01735643) | West German Center of Diabetes and Health | 2011-01-01 |
| Study of AC-201 in Patients With Type 2 Diabetes Mellitus (NCT01276106) | TWi Biotechnology, Inc. | 2011-01-01 |
| Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes Medication (NCT01293578) | Mayo Clinic | 2011-01-01 |
| Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients (NCT01599338) | Centre Hospitalier Universitaire Dijon | 2011-01-01 |
| Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin (NCT01310452) | Fudan University | 2011-01-01 |
| Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial) (NCT01181674) | Population Health Research Institute | 2011-01-01 |
| Effectiveness of Sitagliptin in Glycemic Control in Real World (NCT01316835) | Chang Gung Memorial Hospital | 2010-12-01 |
| Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery (NCT01257087) | Imperial College London | 2010-12-01 |
| Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients (NCT01257451) | Novartis Pharmaceuticals | 2010-12-01 |
| Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM (NCT01694173) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2010-12-01 |
| Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) (NCT01076088) | Merck Sharp & Dohme LLC | 2010-11-15 |
| Amiloride for Resistant Hypertension (NCT02122731) | Ib Abildgaard Jacobsen | 2010-11-01 |
| A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients (NCT01242228) | Astellas Pharma Inc | 2010-10-21 |
| A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients (NCT01242202) | Astellas Pharma Inc | 2010-10-21 |
| A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006) (NCT01217073) | Merck Sharp & Dohme LLC | 2010-10-08 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients (NCT01221545) | AstraZeneca | 2010-10-01 |
| Vascular Effects of Sitagliptin in Diabetes Mellitus (NCT01096277) | Hannover Medical School | 2010-10-01 |
| Orthogonal Polarisation Study in Young, Elderly and Type 2 Diabetics (NCT01476384) | Maastricht University Medical Center | 2010-10-01 |
| Phase 4 Study in the Elderly Patients With T2DM (NCT01238978) | Novartis | 2010-10-01 |
| Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria (NCT01230034) | University of Pavia | 2010-10-01 |
| Reducing Sedentary Behaviour in Young Adults at Risk of Diabetes (NCT01301196) | Loughborough University | 2010-10-01 |
| Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride (NCT01233622) | Novartis | 2010-10-01 |
| Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus (NCT01191320) | Repros Therapeutics Inc. | 2010-10-01 |
| A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia (NCT01212328) | Public Health Foundation of India | 2010-10-01 |
| Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use (NCT01223456) | AstraZeneca | 2010-10-01 |
| Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients (NCT01521624) | Tehran University of Medical Sciences | 2010-10-01 |
| Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy (NCT01240759) | Shionogi | 2010-10-01 |
| Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166 (NCT01201928) | Mannkind Corporation | 2010-10-01 |